GenoPalate analyzes genetic data, demographics, and lifestyle information to deliver personalized insights for optimal healthy eating.
GenoPalate has raised $250K in total funding. The most recent round was Undisclosed. The last funding was announced in March 2026.
GenoPalate's investors include gener8tor, Target Takeoff, BrightStar Wisconsin Foundation, Neil Giugno.
GenoPalate is headquartered in Wauwatosa, United States.
GenoPalate analyzes genetic data, demographics, and lifestyle information to deliver personalized insights for optimal healthy eating.
GenoPalate is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GenoPalate — Funding & Investors." VCBacked, March 4, 2026, https://www.vcbacked.co/company/genopalate. Accessed September 14, 2026.
VCBacked. (2026). GenoPalate — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/genopalate
{{cite web |title=GenoPalate — Funding & Investors |url=https://www.vcbacked.co/company/genopalate |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated